Signaturefd, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,854 shares of ALNY stock, worth $469,710. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,854

Previous 1,383 34.06%

Holding current value

$469,710

Previous $336,000 51.49%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$233.81 - $287.01 $110,124 - $135,181	471 Added 34.06%	1,854 $509,000
Q2 2024 Jul 29, 2024	BUY	$143.31 - $247.0 $40,700 - $70,148	284 Added 25.84%	1,383 $336,000
Q1 2024 May 03, 2024	SELL	$146.51 - $198.2 $13,185 - $17,838	-90 Reduced 7.57%	1,099 $164,000
Q4 2023 Jan 31, 2024	BUY	$151.41 - $196.57 $2,119 - $2,751	14 Added 1.19%	1,189 $227,000
Q3 2023 Nov 03, 2023	SELL	$170.77 - $211.65 $84,189 - $104,343	-493 Reduced 29.56%	1,175 $208,000
Q2 2023 Aug 01, 2023	BUY	$185.01 - $212.05 $41,257 - $47,287	223 Added 15.43%	1,668 $316,000
Q1 2023 Apr 28, 2023	SELL	$182.66 - $235.53 $29,042 - $37,449	-159 Reduced 9.91%	1,445 $289,000
Q4 2022 Jan 27, 2023	BUY	$185.53 - $241.31 $10,946 - $14,237	59 Added 3.82%	1,604 $381,000
Q3 2022 Nov 08, 2022	BUY	$138.54 - $232.0 $146,436 - $245,224	1,057 Added 216.6%	1,545 $309,000
Q2 2022 Aug 10, 2022	SELL	$120.42 - $169.29 $61,414 - $86,337	-510 Reduced 51.1%	488 $71,000
Q1 2022 May 02, 2022	BUY	$127.18 - $173.91 $9,538 - $13,043	75 Added 8.13%	998 $163,000
Q4 2021 Jan 25, 2022	SELL	$159.56 - $209.29 $4,627 - $6,069	-29 Reduced 3.05%	923 $157,000
Q3 2021 Oct 28, 2021	BUY	$169.75 - $207.73 $2,037 - $2,492	12 Added 1.28%	952 $180,000
Q2 2021 Jul 26, 2021	BUY	$128.63 - $176.89 $17,493 - $24,057	136 Added 16.92%	940 $159,000
Q1 2021 Apr 30, 2021	SELL	$126.83 - $175.69 $18,897 - $26,177	-149 Reduced 15.63%	804 $114,000
Q4 2020 Feb 11, 2021	BUY	$122.97 - $147.0 $58,164 - $69,531	473 Added 98.54%	953 $124,000
Q3 2020 Nov 03, 2020	BUY	$121.19 - $165.49 $29,691 - $40,545	245 Added 104.26%	480 $70,000
Q2 2020 Jul 30, 2020	BUY	$104.21 - $156.44 $4,689 - $7,039	45 Added 23.68%	235 $35,000
Q1 2020 Apr 23, 2020	BUY	$93.12 - $133.99 $13,129 - $18,892	141 Added 287.76%	190 $21,000
Q4 2019 Feb 05, 2020	BUY	$74.51 - $124.23 $1,266 - $2,111	17 Added 53.13%	49 $6,000
Q2 2019 Jul 31, 2019	BUY	$65.86 - $92.79 $2,107 - $2,969	32 New	32 $2,000
Q4 2018 Feb 13, 2019	SELL	$62.67 - $88.33 $3,822 - $5,388	-61 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $3,090 - $3,773	35 Added 134.62%	61 $6,000
Q1 2018 May 08, 2018	BUY	$115.92 - $148.54 $3,013 - $3,862	26 New	26 $3,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account